Related references
Note: Only part of the references are listed.Significance of CD47 and Its Association With Tumor Immune Microenvironment Heterogeneity in Ovarian Cancer
Lan Yu et al.
FRONTIERS IN IMMUNOLOGY (2021)
Characterizing Endocrine Status, Tumor Hypoxia and Immunogenicity for Therapy Success in Epithelial Ovarian Cancer
Madison Pereira et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
The Cancer Stem Cell Niche in Ovarian Cancer and Its Impact on Immune Surveillance
Srishti Jain et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
LncRNA TCF7 Promotes Epithelial Ovarian Cancer Viability, Mobility and Stemness via Regulating ITGB8
Changlei Su et al.
FRONTIERS IN ONCOLOGY (2021)
Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39)
Kathleen N. Moore et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
NK Cell-Mediated Eradication of Ovarian Cancer Cells with a Novel Chimeric Antigen Receptor Directed against CD44
Ruediger Klapdor et al.
BIOMEDICINES (2021)
Targeting Ovarian Cancer Stem Cells by Dual Inhibition of HOTAIR and DNA Methylation
Weini Wang et al.
MOLECULAR CANCER THERAPEUTICS (2021)
LINC00115 promotes stemness and inhibits apoptosis of ovarian cancer stem cells by upregulating SOX9 and inhibiting the Wnt/β-catenin pathway through competitively binding to microRNA-30a
Rui Hou et al.
CANCER CELL INTERNATIONAL (2021)
LncRNA WDFY3-AS2 promotes cisplatin resistance and the cancer stem cell in ovarian cancer by regulating hsa-miR-139-5p/SDC4 axis
Yue Wu et al.
CANCER CELL INTERNATIONAL (2021)
Chemokine CCL20 promotes the paclitaxel resistance of CD44+CD117+ cells via the Notch1 signaling pathway in ovarian cancer
Min Chen et al.
MOLECULAR MEDICINE REPORTS (2021)
The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy Failure
Claudia Galassi et al.
CELLS (2021)
Immune checkpoint inhibitors in ovarian cancer: where do we stand?
Alexandra Leary et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2021)
First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors
Gerald Falchook et al.
ECLINICALMEDICINE (2021)
Chimeric Antigen receptor-T (CAR-T) cells targeting Epithelial cell adhesion molecule (EpCAM) can inhibit tumor growth in ovarian cancer mouse model
Juan Fu et al.
JOURNAL OF VETERINARY MEDICAL SCIENCE (2021)
A Study of CD44 Positive Cancer Cells in Epithelial Ovarian Cancer and their Correlation with P53 And Ki67
Ketaki Kar et al.
JOURNAL OF LABORATORY PHYSICIANS (2021)
Aldehyde dehydrogenase inhibitors promote DNA damage in ovarian cancer and synergize with ATM/ATR inhibitors
Edward Grimley et al.
THERANOSTICS (2021)
Dormant disseminated tumor cells and cancer stem/progenitor-like cells: Similarities and opportunities
Omri Hen et al.
SEMINARS IN CANCER BIOLOGY (2020)
Pembrolizumab for advanced anal squamous cell carcinoma (ASCC): Results from the multicohort, phase II KEYNOTE-158 study
Aurelien Marabelle et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Adipocyte-Induced FABP4 Expression in Ovarian Cancer Cells Promotes Metastasis and Mediates Carboplatin Resistance
Abir Mukherjee et al.
CANCER RESEARCH (2020)
A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer
Amit M. Oza et al.
CLINICAL CANCER RESEARCH (2020)
Demcizumab combined with paclitaxel for platinum-resistant ovarian, primary peritoneal, and fallopian tube cancer: The SIERRA open-label phase Ib trial
Robert L. Coleman et al.
GYNECOLOGIC ONCOLOGY (2020)
Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness
Sandra Munoz-Galvan et al.
MOLECULAR CANCER (2020)
Overcoming Resistance to Platinum-Based Drugs in Ovarian Cancer by Salinomycin and Its Derivatives-An In Vitro Study
Marcin Michalak et al.
MOLECULES (2020)
Comparison of the Genomic Profile of Cancer Stem Cells and Their Non-Stem Counterpart: The Case of Ovarian Cancer
Elena Laura Mazzoldi et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Epigenetic Attire in Ovarian Cancer: The Emperor's New Clothes
Daniela Matei et al.
CANCER RESEARCH (2020)
The Ovarian Cancer Tumor Immune Microenvironment (TIME) as Target for Therapy: A Focus on Innate Immunity Cells as Therapeutic Effectors
Denisa Baci et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Influence of Innate Immunity on Cancer Cell Stemness
Anna Pasto et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Global DNA Hypomethylation in Epithelial Ovarian Cancer: Passive Demethylation and Association with Genomic Instability
Wa Zhang et al.
CANCERS (2020)
Ovarian Cancer, Cancer Stem Cells and Current Treatment Strategies: A Potential Role of Magmas in the Current Treatment Methods
Nuzhat Ahmed et al.
CELLS (2020)
Novel Therapeutic Strategies for Ovarian Cancer Stem Cells
Nastassja Terraneo et al.
FRONTIERS IN ONCOLOGY (2020)
Tumour-associated neutrophils orchestrate intratumoural IL-8-driven immune evasion through Jagged2 activation in ovarian cancer
Moran Yang et al.
BRITISH JOURNAL OF CANCER (2020)
Targeting Cancer Stem Cells to Overcome Therapy Resistance in Ovarian Cancer
Sandra Munoz-Galvan et al.
CELLS (2020)
Phase II clinical trial of metformin as a cancer stem cell-targeting agent in ovarian cancer
Jason R. Brown et al.
JCI INSIGHT (2020)
Mitophagy, Mitochondrial Homeostasis, and Cell Fate
Kaili Ma et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Immunotherapy Advances for Epithelial Ovarian Cancer
Erin G. Hartnett et al.
CANCERS (2020)
How Autophagy Shapes the Tumor Microenvironment in Ovarian Cancer
Alessandra Ferraresi et al.
FRONTIERS IN ONCOLOGY (2020)
NOTCH signalling in ovarian cancer angiogenesis
Jose Alejandro Perez-Fidalgo et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Metformin and ovarian cancer: the evidence
Elina Urpilainen et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
The current paradigm and challenges ahead for the dormancy of disseminated tumor cells
Emma Risson et al.
NATURE CANCER (2020)
Enrichment of cancer-initiating cells from colon cancer cells through porous polymeric membranes by a membrane filtration method
Tzu-Cheng Sung et al.
JOURNAL OF MATERIALS CHEMISTRY B (2020)
Immune vulnerability of ovarian cancer stem-like cells due to low CD47 expression is protected by surrounding bulk tumor cells
Chih-Long Chang et al.
ONCOIMMUNOLOGY (2020)
Emerging Importance of Survivin in Stem Cells and Cancer: the Development of New Cancer Therapeutics
Neerada Meenakshi Warrier et al.
STEM CELL REVIEWS AND REPORTS (2020)
Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
Aurelien Marabelle et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Inhibition of the Wnt/beta-catenin pathway enhances antitumor immunity in ovarian cancer
David W. Doo et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
A first-in-human phase 1a study of the bispecific anti-DLL4/anti-VEGF antibody navicixizumab (OMP-305B83) in patients with previously treated solid tumors
Antonio Jimeno et al.
INVESTIGATIONAL NEW DRUGS (2019)
MiR-1180 from bone marrow MSCs promotes cell proliferation and glycolysis in ovarian cancer cells via SFRP1/Wnt pathway
Jinghui Hu et al.
CANCER CELL INTERNATIONAL (2019)
Spleen Tyrosine Kinase-Mediated Autophagy Is Required for Epithelial-Mesenchymal Plasticity and Metastasis in Breast Cancer
Aparna Shinde et al.
CANCER RESEARCH (2019)
Autophagy and cancer stem cells: molecular mechanisms and therapeutic applications
Francesca Nazio et al.
CELL DEATH AND DIFFERENTIATION (2019)
LncRNA AWPPH promotes the proliferation, migration and invasion of ovarian carcinoma cells via activation of the Wnt/-catenin signaling pathway
Guangyu Yu et al.
MOLECULAR MEDICINE REPORTS (2019)
Concise Review: Targeting Cancer Stem Cells and Their Supporting Niche Using Oncolytic Viruses
Mathieu J. F. Crupi et al.
STEM CELLS (2019)
Mutational anc Anticenic Lancsca Tumor Procression anc Cancer Immunotheraoy
Ilio Vitale et al.
TRENDS IN CELL BIOLOGY (2019)
Metabolism-Based Therapeutic Strategies Targeting Cancer Stem Cells
Petra Jagust et al.
FRONTIERS IN PHARMACOLOGY (2019)
Role of Microenvironment on the Fate of Disseminating Cancer Stem Cells
Vincenzo Ingangi et al.
FRONTIERS IN ONCOLOGY (2019)
Therapeutic Targeting of Cancer Stem Cells: Integrating and Exploiting the Acidic Niche
Catherine Vander Linden et al.
FRONTIERS IN ONCOLOGY (2019)
Antibody-Drug Conjugates (ADC) Against Cancer Stem-Like Cells (CSC) - Is There Still Room for Optimism?
Fabrizio Marcucci et al.
FRONTIERS IN ONCOLOGY (2019)
M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression
Xiang-Yang Zeng et al.
CANCER BIOLOGY & THERAPY (2019)
DFMO and 5-Azacytidine Increase M1 Macrophages in the Tumor Microenvironment of Murine Ovarian Cancer
Meghan Travers et al.
CANCER RESEARCH (2019)
A phase II randomized study of avelumab plus entinostat versus avelumab plus placebo in patients (pts) with advanced epithelial ovarian cancer (EOC).
Karen Anne Cadoo et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
A juxtacrine/paracrine loop between C-Kit and stem cell factor promotes cancer stem cell survival in epithelial ovarian cancer
Elena Laura Mazzoldi et al.
CELL DEATH & DISEASE (2019)
The Evolving Landscape of Cancer Stem Cells and Ways to Overcome Cancer Heterogeneity
Hiroaki Taniguchi et al.
CANCERS (2019)
A Role for NF-κB in Organ Specific Cancer and Cancer Stem Cells
Christian Kaltschmidt et al.
CANCERS (2019)
A Novel ALDH1A1 Inhibitor Targets Cells with Stem Cell Characteristics in Ovarian Cancer
Nkechiyere G. Nwani et al.
CANCERS (2019)
Overexpression of long noncoding RNA HOXB-AS3 indicates an unfavorable prognosis and promotes tumorigenesis in epithelial ovarian cancer via Wnt/beta-catenin signaling pathway
Xiao-hong Zhuang et al.
BIOSCIENCE REPORTS (2019)
Notch2 pathway mediates breast cancer cellular dormancy and mobilisation in bone and contributes to haematopoietic stem cell mimicry
Mattia Capulli et al.
BRITISH JOURNAL OF CANCER (2019)
Stem cells in tissues, organoids, and cancers
Xusheng Wang
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Ovarian cancer-derived exosomes promote tumour metastasis in vivo: an effect modulated by the invasiveness capacity of their originating cells
Mona Alharbi et al.
CLINICAL SCIENCE (2019)
MicroRNA-654-5p suppresses ovarian cancer development impacting on MYC, WNT and AKT pathways
Blanca Majem et al.
ONCOGENE (2019)
Role of cancer-associated fibroblasts in tumor structure, composition and the microenvironment in ovarian cancer
Wei Sun et al.
ONCOLOGY LETTERS (2019)
Ovarian cancer stem cells and macrophages reciprocally interact through the WNT pathway to promote pro-tumoral and malignant phenotypes in 3D engineered microenvironments
Shreya Raghavan et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Implication for Cancer Stem Cells in Solid Cancer Chemo-Resistance: Promising Therapeutic Strategies Based on the Use of HDAC Inhibitors
Maria Serena Roca et al.
JOURNAL OF CLINICAL MEDICINE (2019)
The Role of Cancer Stem Cells and Mechanical Forces in Ovarian Cancer Metastasis
Michael E. Bregenzer et al.
CANCERS (2019)
Ovarian Cancer Stemness: Biological and Clinical Implications for Metastasis and Chemotherapy Resistance
Takeshi Motohara et al.
CANCERS (2019)
Ovarian Cancer Stem Cells: Role in Metastasis and Opportunity for Therapeutic Targeting
Xingyue Zong et al.
CANCERS (2019)
The Role of Intra-Tumoral Heterogeneity and Its Clinical Relevance in Epithelial Ovarian Cancer Recurrence and Metastasis
Cai M. Roberts et al.
CANCERS (2019)
Cancer Stem Cells: From Historical Roots to a New Perspective
Jean-Pascal Capp
JOURNAL OF ONCOLOGY (2019)
Presence and role of stem cells in ovarian cancer
Natasa Kenda Suster et al.
WORLD JOURNAL OF STEM CELLS (2019)
Mechanobiology of Cancer Stem Cells and Their Niche
Ankit Roy Choudhury et al.
CANCER MICROENVIRONMENT (2019)
A phase 1b dose escalation study of ipafricept (OMP-54F28) in combination with paclitaxel and carboplatin in patients with recurrent platinum-sensitive ovarian cancer
Kathleen N. Moore et al.
GYNECOLOGIC ONCOLOGY (2019)
CSCs in Breast Cancer-One Size Does Not Fit All: Therapeutic Advances in Targeting Heterogeneous Epithelial and Mesenchymal CSCs
Andrew Sulaiman et al.
CANCERS (2019)
Tumor Cell Dormancy: Threat or Opportunity in the Fight against Cancer
Rana Jahanban-Esfahlan et al.
CANCERS (2019)
Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness
Kha-Liang Lee et al.
CANCERS (2019)
Bioactive lipids in cancer stem cells
Romana-Rea Begicevic et al.
WORLD JOURNAL OF STEM CELLS (2019)
Let-7c regulates proliferation and osteodifferentiation of human adipose-derived mesenchymal stem cells under oxidative stress by targeting SCD-1
Zihui Zhou et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2019)
Wnt Signaling in Ovarian Cancer Stemness, EMT, and Therapy Resistance
Miriam Teeuwssen et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities
Maria Laura De Angelis et al.
CANCERS (2019)
Verteporfin-Loaded Lipid Nanoparticles Improve Ovarian Cancer Photodynamic Therapy In Vitro and In Vivo
Thierry Michy et al.
CANCERS (2019)
Post-transcriptional regulations of cancer stem cell homeostasis
Nabila Berabez et al.
CURRENT OPINION IN ONCOLOGY (2019)
Neutrophils facilitate ovarian cancer premetastatic niche formation in the omentum
WonJae Lee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment
Takeshi Motohara et al.
ONCOGENE (2019)
Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth
Karen McLean et al.
ONCOGENE (2019)
MicroRNA-16 inhibits migration and invasion via regulation of the Wnt/β-catenin signaling pathway in ovarian cancer
Nan Li et al.
ONCOLOGY LETTERS (2019)
Dickkopf-3 links HSF1 and YAP/TAZ signalling to control aggressive behaviours in cancer-associated fibroblasts
Nicola Ferrari et al.
NATURE COMMUNICATIONS (2019)
Immune profiling and identification of prognostic immune-related risk factors in human ovarian cancer
Emelie Radestad et al.
ONCOIMMUNOLOGY (2019)
Ovarian cancer stem cells and targeted therapy
Vahideh Keyvani et al.
JOURNAL OF OVARIAN RESEARCH (2019)
BRCA Genes: The Role in Genome Stability, Cancer Sternness and Therapy Resistance
Ielizaveta Gorodetska et al.
JOURNAL OF CANCER (2019)
Long non-coding RNA CCAT2 promotes epithelial-mesenchymal transition involving Wnt/β-catenin pathway in epithelial ovarian carcinoma cells
Beidi Wang et al.
ONCOLOGY LETTERS (2018)
Cancer-associated fibroblasts regulate the biological behavior of cancer cells and stroma in gastric cancer (Review)
Qian Zhang et al.
ONCOLOGY LETTERS (2018)
LGR5 and LGR6 in stem cell biology and ovarian cancer
Adam J. Schindler et al.
ONCOTARGET (2018)
Reduction of MHC-I expression limits T-lymphocyte-mediated killing of Cancer-initiating cells
Brian J. Morrison et al.
BMC CANCER (2018)
Dual Src and MEK Inhibition Decreases Ovarian Cancer Growth and Targets Tumor Initiating Stem-Like Cells
Fiona Simpkins et al.
CLINICAL CANCER RESEARCH (2018)
Different Lipid Regulation in Ovarian Cancer: Inhibition of the Immune System
Christina Wefers et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Chemoresistance in ovarian cancer: exploiting cancer stem cell metabolism
Shan-Shan Li et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2018)
Surface markers of cancer stem-like cells of ovarian cancer and their clinical relevance
Aleksandra Klemba et al.
Wspolczesna Onkologia-Contemporary Oncology (2018)
ALDH1A2 suppresses epithelial ovarian cancer cell proliferation and migration by downregulating STAT3
Yichen Wang et al.
ONCOTARGETS AND THERAPY (2018)
Are ovarian cancer stem cells the target for innovative immunotherapy?
Liang Wang et al.
ONCOTARGETS AND THERAPY (2018)
Activation of hedgehog signaling and its association with cisplatin resistance in ovarian epithelial tumors
Xueling Song et al.
ONCOLOGY LETTERS (2018)
Identification of common differentially-expressed miRNAs in ovarian cancer cells and their exosomes compared with normal ovarian surface epithelial cell cells
Shitao Zhang et al.
ONCOLOGY LETTERS (2018)
Comparison of benign peritoneal fluid- and ovarian cancer ascites-derived extracellular vesicle RNA biomarkers
Cindy M. Yamamoto et al.
JOURNAL OF OVARIAN RESEARCH (2018)
RANTES and IL-6 cooperate in inducing a more aggressive phenotype in breast cancer cells
Marianna Gallo et al.
Oncotarget (2018)
Momelotinib decreased cancer stem cell associated tumor burden and prolonged disease-free remission period in a mouse model of human ovarian cancer
Emily Chan et al.
Oncotarget (2018)
Depletion of HDAC1, 7 and 8 by Histone Deacetylase Inhibition Confers Elimination of Pancreatic Cancer Stem Cells in Combination with Gemcitabine
Mao-Hua Cai et al.
SCIENTIFIC REPORTS (2018)
HIF-1α hampers dendritic cell function and Th1 generation during chronic visceral leishmaniasis
Akil Hammami et al.
SCIENTIFIC REPORTS (2018)
Mesothelial cells facilitate cancer stem-like properties in spheroids of ovarian cancer cells
Akemi Shishido et al.
ONCOLOGY REPORTS (2018)
The role of cancer stem cells in the modulation of anti-tumor immune responses
Cristina Maccalli et al.
SEMINARS IN CANCER BIOLOGY (2018)
Tumor Antigen Escape from CAR T-cell Therapy
Robbie G. Majzner et al.
CANCER DISCOVERY (2018)
Epigenetic Crosstalk between the Tumor Microenvironment and Ovarian Cancer Cells: A Therapeutic Road Less Traveled
Yuliya Klymenko et al.
CANCERS (2018)
Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells
Nuzhat Ahmed et al.
SEMINARS IN CANCER BIOLOGY (2018)
Cancer stem cell impact on clinical oncology
Mariel E. Toledo-Guzman et al.
WORLD JOURNAL OF STEM CELLS (2018)
CD133 Promotes Adhesion to the Ovarian Cancer Metastatic Niche
Lynn Roy et al.
CANCER GROWTH AND METASTASIS (2018)
Therapeutic approaches targeting cancer stem cells
Yunzhi Pan et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2018)
Up-regulation of long non-coding RNA SNHG20 promotes ovarian cancer progression via Wnt/β-catenin signaling
Shanyang He et al.
BIOSCIENCE REPORTS (2018)
Human epidermal growth factor receptor targeted inhibitors for the treatment of ovarian cancer
Maria Bonello et al.
CANCER BIOLOGY & MEDICINE (2018)
Ovarian cancer stem cells promote tumour immune privilege and invasion via CCL5 and regulatory T cells
Y. You et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2018)
Serglycin in tumor microenvironment promotes non-small cell lung cancer aggressiveness in a CD44-dependent manner
J-Y Guo et al.
ONCOGENE (2017)
Identification of a cancer stem cell-specific function for the histone deacetylases, HDAC1 and HDAC7, in breast and ovarian cancer
A. E. Witt et al.
ONCOGENE (2017)
Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium
Ilary Ruscito et al.
EUROPEAN JOURNAL OF CANCER (2017)
MicroRNA-219-5p inhibits the proliferation, migration, and invasion of epithelial ovarian cancer cells by targeting the Twist/Wnt/β-catenin signaling pathway
Chunyan Wei et al.
GENE (2017)
Metabolic reprogramming ensures cancer cell survival despite oncogenic signaling blockade
Hui-wen Lue et al.
GENES & DEVELOPMENT (2017)
Improved Killing of Ovarian Cancer Stem Cells by Combining a Novel Chimeric Antigen Receptor-Based Immunotherapy and Chemotherapy
Ruediger Klapdor et al.
HUMAN GENE THERAPY (2017)
Phase I trial of the oral smoothened inhibitor sonidegib in combination with paclitaxel in patients with advanced solid tumors
A. Stathis et al.
INVESTIGATIONAL NEW DRUGS (2017)
Salinomycin reduces stemness and induces apoptosis on human ovarian cancer stem cell
Hyun-Gyo Lee et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2017)
Mesothelial-to-mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer
Angela Rynne-Vidal et al.
JOURNAL OF PATHOLOGY (2017)
Ovarian cancer stem cells: still an elusive entity?
Michela Lupia et al.
MOLECULAR CANCER (2017)
Cancer stem cells revisited
Eduard Batlle et al.
NATURE MEDICINE (2017)
Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
β-catenin downregulates Dicer to promote ovarian cancer metastasis
S. K. Y. To et al.
ONCOGENE (2017)
Exosomes derived from hypoxic epithelial ovarian cancer deliver microRNA-940 to induce macrophage M2 polarization
Xin Chen et al.
ONCOLOGY REPORTS (2017)
CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways
Kiyoko Nakamura et al.
ONCOLOGY REPORTS (2017)
Three Combined Treatments, a Novel HDAC Inhibitor OBP-801/YM753, 5-Fluorouracil, and Paclitaxel, Induce G(2) Phase Arrest Through the p38 Pathway in Human Ovarian Cancer Cells
Makoto Akiyama et al.
ONCOLOGY RESEARCH (2017)
Ovarian cancer stem cells more questions than answers
Petronella Beatrix Ottevanger
SEMINARS IN CANCER BIOLOGY (2017)
Autophagy inhibition reduces chemoresistance and tumorigenic potential of human ovarian cancer stem cells
Anna Pagotto et al.
CELL DEATH & DISEASE (2017)
Expression of miR-146a in patients with ovarian cancer and its clinical significance
Milosz Wilczynski et al.
ONCOLOGY LETTERS (2017)
Human CAFs promote lymphangiogenesis in ovarian cancer via the Hh-VEGF-C signaling axis
Rui Wei et al.
Oncotarget (2017)
Intraperitoneal immunotherapy with T cells stably and transiently expressing anti-EpCAM CAR in xenograft models of peritoneal carcinomatosis
Wei Xia Ang et al.
ONCOTARGET (2017)
Therapeutic targeting using tumor specific peptides inhibits long noncoding RNA HOTAIR activity in ovarian and breast cancer
Ali R. Ozes et al.
SCIENTIFIC REPORTS (2017)
The Crosstalk between Ovarian Cancer Stem Cell Niche and the Tumor Microenvironment
Manuel Varas-Godoy et al.
STEM CELLS INTERNATIONAL (2017)
Inhibition of the integrin/FAK signaling axis and c-Myc synergistically disrupts ovarian cancer malignancy
B. Xu et al.
ONCOGENESIS (2017)
Control of Tumor Initiation by NKG2D Naturally Expressed on Ovarian Cancer Cells
Xin Cai et al.
NEOPLASIA (2017)
The safety, efficacy, and treatment outcomes of a combination of low-dose decitabine treatment in patients with recurrent ovarian cancer
Yan Zhang et al.
ONCOIMMUNOLOGY (2017)
Complex Determinants of Epithelial: Mesenchymal Phenotypic Plasticity in Ovarian Cancer
Yuliya Klymenko et al.
CANCERS (2017)
The Unique Molecular and Cellular Microenvironment of Ovarian Cancer
Thomas Worzfeld et al.
FRONTIERS IN ONCOLOGY (2017)
Functional prediction of long non-coding RNAs in ovarian cancer-associated fibroblasts indicate a potential role in metastasis
Fatemeh Vafaee et al.
SCIENTIFIC REPORTS (2017)
NFκB Promotes Ovarian Tumorigenesis via Classical Pathways That Support Proliferative Cancer Cells and Alternative Pathways That Support ALDH+ Cancer Stem-like Cells
Carrie D. House et al.
CANCER RESEARCH (2017)
NF-κB Participates in the Stem Cell Phenotype of Ovarian Cancer Cells
Carolina Gonzalez-Torres et al.
ARCHIVES OF MEDICAL RESEARCH (2017)
LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway
Ying Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Tumour acidosis: from the passenger to the driver's seat
Cyril Corbet et al.
NATURE REVIEWS CANCER (2017)
Dendritic cell rehab: new strategies to unleash therapeutic immunity in ovarian cancer
Chang-Suk Chae et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Suppression of endothelial cell migration by tumor associated macrophage-derived exosomes is reversed by epithelial ovarian cancer exosomal lncRNA
Quanfeng Wu et al.
CANCER CELL INTERNATIONAL (2017)
SOX2 is required to maintain cancer stem cells in ovarian cancer
Yiping Wen et al.
CANCER SCIENCE (2017)
Epigenetic therapy for the treatment of epithelial ovarian cancer: A clinical review
Haller J. Smith et al.
GYNECOLOGIC ONCOLOGY REPORTS (2017)
TWEAK-stimulated macrophages inhibit metastasis of epithelial ovarian cancer via exosomal shuttling of microRNA
Yuan Hu et al.
CANCER LETTERS (2017)
CAF-derived HGF promotes cell proliferation and drug resistance by up-regulating the c-Met/PI3K/Akt and GRP78 signalling in ovarian cancer cells
Wei Deying et al.
BIOSCIENCE REPORTS (2017)
Hypoxia promotes the phenotypic change of aldehyde dehydrogenase activity of breast cancer stem cells
Akira Shiraishi et al.
CANCER SCIENCE (2017)
Glioblastoma Cancer Stem Cells Evade Innate Immune Suppression of Self-Renewal through Reduced TLR4 Expression
Alvaro G. Alvarado et al.
CELL STEM CELL (2017)
VEGFA activates an epigenetic pathway upregulating ovarian cancer-initiating cells
Kibeom Jang et al.
EMBO MOLECULAR MEDICINE (2017)
CD133 confers cancer stem-like cell properties by stabilizing EGFR-AKT signaling in hepatocellular carcinoma
Jae-Woo Jang et al.
CANCER LETTERS (2017)
Long Noncoding RNA LINC00092 Acts in Cancer-Associated Fibroblasts to Drive Glycolysis and Progression of Ovarian Cancer
Linjie Zhao et al.
CANCER RESEARCH (2017)
Lipid Desaturation Is a Metabolic Marker and Therapeutic Target of Ovarian Cancer Stem Cells
Junjie Li et al.
CELL STEM CELL (2017)
MicroRNA-136 inhibits cancer stem cell activity and enhances the anti-tumor effect of paclitaxel against chemoresistant ovarian cancer cells by targeting Notch3
Ju-Yeon Jeong et al.
CANCER LETTERS (2017)
Targeting CD133 in the enhancement of chemosensitivity in oral squamous cell carcinoma-derived side population cancer stem cells
Cheng-Chia Yu et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2016)
Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer
Jessica Gobbo et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer
Jessica Gobbo et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
The Dualistic Model of Ovarian Carcinogenesis Revisited, Revised, and Expanded
Robert J. Kurman et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Ovarian cancer stem-like cells differentiate into endothelial cells and participate in tumor angiogenesis through autocrine CCL5 signaling
Shu Tang et al.
CANCER LETTERS (2016)
Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancer
Soochi Kim et al.
CANCER SCIENCE (2016)
Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT
Srinivas Malladi et al.
CELL (2016)
A first-in-human phase I study of the oral Notch inhibitor, LY900009, in patients with advanced cancer
Shubham Pant et al.
EUROPEAN JOURNAL OF CANCER (2016)
Sequential combination therapy of ovarian cancer with cisplatin and γ-secretase inhibitor MK-0752
XiuXiu Chen et al.
GYNECOLOGIC ONCOLOGY (2016)
CD24 is highly useful in differentiating high-grade serous carcinoma from benign and malignant mesothelial cells
Ben Davidson
HUMAN PATHOLOGY (2016)
Inhibition of ALDH1A1 activity decreases expression of drug transporters and reduces chemotherapy resistance in ovarian cancer cell lines
Radoslaw Januchowski et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)
Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study
Russell Vang et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2016)
MicroRNA MiR-214 regulates ovarian cancer cell stemness by targeting p53/Nanog (vol 287, pg 34970, 2012)
Cheng-Xiong Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer
Mingzhu Yin et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Use and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian Cancer
Larissa A. Meyer et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Metronomic chemotherapy prevents therapy-induced stromal activation and induction of tumor-initiating cells
Tze-Sian Chan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
In vitro and in vivo correlates of physiological and neoplastic human Fallopian tube stem cells
Yusuke Yamamoto et al.
JOURNAL OF PATHOLOGY (2016)
CD44 Variant 6 as a Predictive Biomarker for Distant Metastasis in Patients With Epithelial Ovarian Cancer
Takeshi Motohara et al.
OBSTETRICS AND GYNECOLOGY (2016)
Cyclin G2 inhibits epithelial-to-mesenchymal transition by disrupting Wnt/β-catenin signaling
S. Bernaudo et al.
ONCOGENE (2016)
Implications of cancer stem cells in developing therapeutic resistance in oral cancer
Prajna Paramita Naik et al.
ORAL ONCOLOGY (2016)
Cancer-associated fibroblasts in hepatocellular carcinoma
Norio Kubo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1
Chi Lam Au Yeung et al.
NATURE COMMUNICATIONS (2016)
Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells
Maryam Abbaspour Babaei et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2016)
Autocrine interleukin-23 promotes self-renewal of CD133+ ovarian cancer stem-like cells
Dan Wang et al.
ONCOTARGET (2016)
Human carcinoma-associated mesenchymal stem cells promote ovarian cancer chemotherapy resistance via a BMP4/HH signaling loop
Lan G. Coffman et al.
ONCOTARGET (2016)
CD24 promoted cancer cell angiogenesis via Hsp90-mediated STAT3/VEGF signaling pathway in colorectal cancer
Xinying Wang et al.
ONCOTARGET (2016)
The multifaceted role of autophagy in tumor evasion from immune surveillance
Bassam Janji et al.
ONCOTARGET (2016)
CD44 and CD24 coordinate the reprogramming of nasopharyngeal carcinoma cells towards a cancer stem cell phenotype through STAT3 activation
Yao-An Shen et al.
ONCOTARGET (2016)
Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer
Shailendra Kumar Dhar Dwivedi et al.
ONCOTARGET (2016)
Hypoxia-induced CCL28 promotes recruitment of regulatory T cells and tumor growth in liver cancer
Li Ren et al.
ONCOTARGET (2016)
An active IGF-1R-AKT signaling imparts functional heterogeneity in ovarian CSC population
Ram K. Singh et al.
SCIENTIFIC REPORTS (2016)
Cancer-Associated Myeloid Regulatory Cells
Yannick De Vlaeminck et al.
FRONTIERS IN IMMUNOLOGY (2016)
Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: Discovery and validation studies
Karin Hellner et al.
EBIOMEDICINE (2016)
Cross Talk between Cancer and Mesenchymal Stem Cells through extracellular vesicles Carrying Nucleic Acids
Tatiana Lopatina et al.
FRONTIERS IN ONCOLOGY (2016)
WNT7A Regulation by miR-15b in Ovarian Cancer
James A. MacLean et al.
PLOS ONE (2016)
Stemness and chemoresistance in epithelial ovarian carcinoma cells under shear stress
Carman K. M. Ip et al.
SCIENTIFIC REPORTS (2016)
Human endometrial mesenchymal stem cells exhibit intrinsic anti-tumor properties on human epithelial ovarian cancer cells
Shixia Bu et al.
SCIENTIFIC REPORTS (2016)
Tumor Heterogeneity, Single-Cell Sequencing, and Drug Resistance
Felix Schmidt et al.
PHARMACEUTICALS (2016)
The biology and function of fibroblasts in cancer
Raghu Kalluri
NATURE REVIEWS CANCER (2016)
Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis
Tsz-Lun Yeung et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2015)
MiR-939 promotes the proliferation of human ovarian cancer cells by repressing APC2 expression
Xiong Ying et al.
BIOMEDICINE & PHARMACOTHERAPY (2015)
Neutrophils: important contributors to tumor progression and metastasis
Agnieszka Swierczak et al.
CANCER AND METASTASIS REVIEWS (2015)
Phase I study of combination of vorinostat, carboplatin, and gemcitabine in women with recurrent, platinum-sensitive epithelial ovarian, fallopian tube, or peritoneal cancer
Ursula Matulonis et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer
Francisca Tjhay et al.
CANCER SCIENCE (2015)
A Phase I First-in-Human Study of Enoticumab (REGN421), a Fully Human Delta-like Ligand 4 (Dll4) Monoclonal Antibody in Patients with Advanced Solid Tumors
Elena Gabriela Chiorean et al.
CLINICAL CANCER RESEARCH (2015)
Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms
Michele Cioffi et al.
CLINICAL CANCER RESEARCH (2015)
Involvement of Mesenchymal Stem Cells in Cancer Progression and Metastases
Astra I. Chang et al.
CURRENT CANCER DRUG TARGETS (2015)
Secretory autophagy
Marisa Ponpuak et al.
CURRENT OPINION IN CELL BIOLOGY (2015)
A phase II study of single-agent RO4929097, a gamma-secretase inhibitor of Notch signaling, in patients with recurrent platinum-resistant epithelial ovarian cancer: A study of the Princess Margaret, Chicago and California phase II consortia
Ivan Diaz-Padilla et al.
GYNECOLOGIC ONCOLOGY (2015)
Cancer stem-like cells of ovarian clear cell carcinoma are enriched in the ALDH-high population associated with an accelerated scavenging system in reactive oxygen species
T. Mizuno et al.
GYNECOLOGIC ONCOLOGY (2015)
Predictive markers of chemoresistance in advanced stages epithelial ovarian carcinoma
Claire Bonneau et al.
GYNECOLOGIC ONCOLOGY (2015)
The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions
Ben Davidson et al.
HUMAN PATHOLOGY (2015)
Role of CD24 in anoikis resistance of ovarian cancer cells
Yan-hui Li et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2015)
Gene methylation of human ovarian carcinoma stromal progenitor cells promotes tumorigenesis
Chih-Ming Ho et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Ovarian cancer stem-like cells elicit the polarization of M2 macrophages
Qing Zhang et al.
MOLECULAR MEDICINE REPORTS (2015)
Whole-genome characterization of chemoresistant ovarian cancer
Ann-Marie Patch et al.
NATURE (2015)
Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update
Naoko Takebe et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Identifying an ovarian cancer cell hierarchy regulated by bone morphogenetic protein 2
Yun-Jung Choi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Overexpression of SOX2 is involved in paclitaxel resistance of ovarian cancer via the PI3K/Akt pathway
Yang Li et al.
TUMOR BIOLOGY (2015)
A basal-like breast cancer-specific role for SRF-IL6 in YAP-induced cancer stemness
Tackhoon Kim et al.
NATURE COMMUNICATIONS (2015)
Effect of targeted ovarian cancer immunotherapy using ovarian cancer stem cell vaccine
Di Wu et al.
JOURNAL OF OVARIAN RESEARCH (2015)
Accumulation of ALDH1-positive cells after neoadjuvant chemotherapy predicts treatment resistance and prognosticates poor outcome in ovarian cancer
Tiyasha H. Ayub et al.
ONCOTARGET (2015)
FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer
Qipeng Fan et al.
ONCOTARGET (2015)
COL11A1 confers chemoresistance on ovarian cancer cells through the activation of Akt/c/EBPβ pathway and PDK1 stabilization
Yi-Hui Wu et al.
ONCOTARGET (2015)
Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance
Anil Belur Nagaraj et al.
ONCOTARGET (2015)
MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway
Geyan Wu et al.
ONCOTARGET (2015)
Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis
Bin Shang et al.
SCIENTIFIC REPORTS (2015)
Identification of a distinct population of CD133+CXCR4+ cancer stem cells in ovarian cancer
Michele Cioffi et al.
SCIENTIFIC REPORTS (2015)
Combined Effects of Pericytes in the Tumor Microenvironment
Aline Lopes Ribeiro et al.
STEM CELLS INTERNATIONAL (2015)
The Mesothelial Origin of Carcinoma Associated-Fibroblasts in Peritoneal Metastasis
Angela Rynne-Vidal et al.
CANCERS (2015)
Expressions of fatty acid synthase and HER2 are correlated with poor prognosis of ovarian cancer
Yunlang Cai et al.
MEDICAL ONCOLOGY (2015)
Interleukin-17 produced by tumor microenvironment promotes self-renewal of CD133+ cancer stem-like cells in ovarian cancer
T. Xiang et al.
ONCOGENE (2015)
Effective inhibition of c-MET-mediated signaling, growth and migration of ovarian cancer cells is influenced by the ovarian tissue microenvironment
Y. Kwon et al.
ONCOGENE (2015)
β-Catenin-regulated ALDH1A1 is a target in ovarian cancer spheroids
S. Condello et al.
ONCOGENE (2015)
Expression of miR-136 is associated with the primary cisplatin resistance of human epithelial ovarian cancer
Henan Zhao et al.
ONCOLOGY REPORTS (2015)
An Overview of Autophagy: Morphology, Mechanism, and Regulation
Katherine R. Parzych et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
CD24 mediates gastric carcinogenesis and promotes gastric cancer progression via STAT3 activation
Ying-Chao Wang et al.
APOPTOSIS (2014)
DIRAS3 regulates the autophagosome initiation complex in dormant ovarian cancer cells
Zhen Lu et al.
AUTOPHAGY (2014)
Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden
Khalid Abubaker et al.
BMC CANCER (2014)
A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancer
R. M. Glasspool et al.
BRITISH JOURNAL OF CANCER (2014)
Metastatic Consequences of Immune Escape from NK Cell Cytotoxicity by Human Breast Cancer Stem Cells
Bin Wang et al.
CANCER RESEARCH (2014)
Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells
Mario L. Suva et al.
CELL (2014)
Immunobiology of mesenchymal stem cells
S. Ma et al.
CELL DEATH AND DIFFERENTIATION (2014)
Isolation and Characterization of Cancer Stem Cells from High-Grade Serous Ovarian Carcinomas
Qi-zhi He et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2014)
Association of overexpression of hexokinase II with chemoresistance in epithelial ovarian cancer
Dong Hoon Suh et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2014)
TGF-β induces global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells
Horacio Cardenas et al.
EPIGENETICS (2014)
Blockade of CD47-Mediated Cathepsin S/Protease-Activated Receptor 2 Signaling Provides a Therapeutic Target for Hepatocellular Carcinoma
Terence Kin-Wah Lee et al.
HEPATOLOGY (2014)
Involvement of miR-29b signaling in the sensitivity to chemotherapy in patients with ovarian carcinoma
Furong Dai et al.
HUMAN PATHOLOGY (2014)
Pushing tumor cells towards a malignant phenotype: Stimuli from the microenvironment, intercellular communications and alternative roads
Fabrizio Marcucci et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Triptolide reverses hypoxia- induced epithelial- mesenchymal transition and stem- like features in pancreatic cancer by NF- jB downregulation
Li Liu et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Observation of ovarian cancer stem cell behavior and investigation of potential mechanisms of drug resistance in three-dimensional cell culture
Junsong Chen et al.
JOURNAL OF BIOSCIENCE AND BIOENGINEERING (2014)
The malignancy of metastatic ovarian cancer cells is increased on soft matrices through a mechanosensitive Rho-ROCK pathway
Daniel J. McGrail et al.
JOURNAL OF CELL SCIENCE (2014)
New and emerging HDAC inhibitors for cancer treatment
Alison C. West et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer
Gottfried E. Konecny et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Hedgehog Signaling Regulates Drug Sensitivity by Targeting ABC Transporters ABCB1 and ABCG2 in Epithelial Ovarian Cancer
Yi Chen et al.
MOLECULAR CARCINOGENESIS (2014)
Type 1 collagen as a potential niche component for CD133-positive glioblastoma cells
Hiroaki Motegi et al.
NEUROPATHOLOGY (2014)
NF-κB is a critical mediator of BRCA1-induced chemoresistance
M. T. Harte et al.
ONCOGENE (2014)
Ovarian cancer stem cell- specific gene expression profiling and targeted drug prescreening
Yuting Huang et al.
ONCOLOGY REPORTS (2014)
Overexpression of CD133 enhances chemoresistance to 5-fluorouracil by activating the PI3K/Akt/p70S6K pathway in gastric cancer cells
Youlong Zhu et al.
ONCOLOGY REPORTS (2014)
Inhibition of HDAC1 and DNMT1 Modulate RGS10 Expression and Decrease Ovarian Cancer Chemoresistance
Ercan Cacan et al.
PLOS ONE (2014)
Ovarian Cancer Spheroid Cells with Stem Cell-Like Properties Contribute to Tumor Generation, Metastasis and Chemotherapy Resistance through Hypoxia-Resistant Metabolism
Jianqun Liao et al.
PLOS ONE (2014)
FOXM1 Modulates Cisplatin Sensitivity by Regulating EXO1 in Ovarian Cancer
Jinhua Zhou et al.
PLOS ONE (2014)
The MyD88+Phenotype Is an Adverse Prognostic Factor in Epithelial Ovarian Cancer
Charles J. d'Adhemar et al.
PLOS ONE (2014)
ALDH1A1 Maintains Ovarian Cancer Stem Cell-Like Properties by Altered Regulation of Cell Cycle Checkpoint and DNA Repair Network Signaling
Erhong Meng et al.
PLOS ONE (2014)
CD95 and CD95L promote and protect cancer stem cells
Paolo Ceppi et al.
NATURE COMMUNICATIONS (2014)
The side population of ovarian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristics
Maximilian Boesch et al.
ONCOTARGET (2014)
Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation
Anna Pasto et al.
ONCOTARGET (2014)
Notch3 Interactome Analysis Identified WWP2 as a Negative Regulator of Notch3 Signaling in Ovarian Cancer
Jin-Gyoung Jung et al.
PLOS GENETICS (2014)
Epigenetic Potentiation of NY-ESO-1 Vaccine Therapy in Human Ovarian Cancer
Kunle Odunsi et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Cancer stem cell immunology: key to understanding tumorigenesis and tumor immune escape?
Valentin S. Bruttel et al.
FRONTIERS IN IMMUNOLOGY (2014)
Cytokine Secretion Profiling of Human Mesenchymal Stem Cells by Antibody Array
Chae Woon Park et al.
International Journal of Stem Cells (2014)
Mechanisms of disseminated cancer cell dormancy: an awakening field
Maria Soledad Sosa et al.
NATURE REVIEWS CANCER (2014)
Phase 1/1b study of the FAK inhibitor defactinib (VS-6063) in combination with weekly paclitaxel for advanced ovarian cancer.
Manish R. Patel et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Integrated Analyses Identify a Master MicroRNA Regulatory Network for the Mesenchymal Subtype in Serous Ovarian Cancer
Da Yang et al.
CANCER CELL (2013)
Salinomycin inhibits Akt/NF-κB and induces apoptosis in cisplatin resistant ovarian cancer cells
Bidur Parajuli et al.
CANCER EPIDEMIOLOGY (2013)
TGF-β Modulates Ovarian Cancer Invasion by Upregulating CAF-Derived Versican in the Tumor Microenvironment
Tsz-Lun Yeung et al.
CANCER RESEARCH (2013)
TLR2 enhances ovarian cancer stem cell self-renewal and promotes tumor repair and recurrence
Ilana Chefetz et al.
CELL CYCLE (2013)
Inhibition of focal adhesion kinase (FAK) activity prevents anchorage-independent ovarian carcinoma cell growth and tumor progression
Kristy K. Ward et al.
CLINICAL & EXPERIMENTAL METASTASIS (2013)
Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression
Amy P. N. Skubitz et al.
GYNECOLOGIC ONCOLOGY (2013)
CD44 standard form expression is correlated with high-grade and advanced-stage ovarian carcinoma but not prognosis
Jing Zhang et al.
HUMAN PATHOLOGY (2013)
Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma
Catarina Alisa Liebscher et al.
HUMAN PATHOLOGY (2013)
Myeloid-Derived Suppressor Cells Enhance Stemness of Cancer Cells by Inducing MicroRNA101 and Suppressing the Corepressor CtBP2
Tracy X. Cui et al.
IMMUNITY (2013)
Increased Incidence of Severe Gastrointestinal Events With First-Line Paclitaxel, Carboplatin, and Vorinostat Chemotherapy for Advanced-Stage Epithelial Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
Alberto A. Mendivil et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2013)
Effects and Mechanisms of Anti-CD44 Monoclonal Antibody A3D8 on Proliferation and Apoptosis of Sphere-Forming Cells With Stemness From Human Ovarian Cancer
Yong-Rui Du et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2013)
The Stem-Cell Profile of Ovarian Surface Epithelium is Reproduced in the Oviductal Fimbriae, with Increased Stem-Cell Marker Density in Distal Parts of the Fimbriae
Nelly Auersperg
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2013)
CD147, CD44, and the Epidermal Growth Factor Receptor (EGFR) Signaling Pathway Cooperate to Regulate Breast Epithelial Cell Invasiveness
G. Daniel Grass et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma
Yvonne T. Tsang et al.
JOURNAL OF PATHOLOGY (2013)
Carcinoma-associated fibroblasts derive from mesothelial cells via mesothelial-to-mesenchymal transition in peritoneal metastasis
Pilar Sandoval et al.
JOURNAL OF PATHOLOGY (2013)
Mesenchymal stem cells enhance ovarian cancer cell infiltration through IL6 secretion in an amniochorionic membrane based 3D model
Cyril Touboul et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden
Khalid Abubaker et al.
MOLECULAR CANCER (2013)
Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche
Andrea Flesken-Nikitin et al.
NATURE (2013)
The epigenetics of epithelial-mesenchymal plasticity in cancer
Wai Leong Tam et al.
NATURE MEDICINE (2013)
Constitutive proteasomal degradation of TWIST-1 in epithelial-ovarian cancer stem cells impacts differentiation and metastatic potential
G. Yin et al.
ONCOGENE (2013)
c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin-ATP-binding cassette G2 signaling
W. K. Chau et al.
ONCOGENE (2013)
ALDH1-High Ovarian Cancer Stem-Like Cells Can Be Isolated from Serous and Clear Cell Adenocarcinoma Cells, and ALDH1 High Expression Is Associated with Poor Prognosis
Takafumi Kuroda et al.
PLOS ONE (2013)
Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells
Yuanyan Wei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
High Frequency of Putative Ovarian Cancer Stem Cells With CD44/CK19 Coexpression Is Associated With Decreased Progression-Free Intervals In Patients With Recurrent Epithelial Ovarian Cancer
Ming Liu et al.
REPRODUCTIVE SCIENCES (2013)
Circulating Tumor Cells
Vicki Plaks et al.
SCIENCE (2013)
CD133 Is Essential for Glioblastoma Stem Cell Maintenance
Paola Brescia et al.
STEM CELLS (2013)
Epithelial Ovarian Cancer-Induced Angiogenic Phenotype of Human Omental Microvascular Endothelial Cells May Occur Independently of VEGF Signaling
Boleslaw K. Winiarski et al.
TRANSLATIONAL ONCOLOGY (2013)
The stem cell markers Oct4A, Nanog and c-Myc are expressed in ascites cells and tumor tissue of ovarian cancer patients
Jiabo Di et al.
CELLULAR ONCOLOGY (2013)
Tumor Endothelial Cells Acquire Drug Resistance by MDR1 Up-Regulation via VEGF Signaling in Tumor Microenvironment
Kosuke Akiyama et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
ALDH1-Bright Epithelial Ovarian Cancer Cells Are Associated with CD44 Expression, Drug Resistance, and Poor Clinical Outcome
Yu-Chi Wang et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
MicroRNA profiling of a CD133+ spheroid-forming subpopulation of the OVCAR3 human ovarian cancer cell line
Eun Ji Nam et al.
BMC MEDICAL GENOMICS (2012)
Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer
Samar Masoumi Moghaddam et al.
CANCER AND METASTASIS REVIEWS (2012)
Immunomonitoring Results of a Phase II/III Study of Malignant Ascites Patients Treated with the Trifunctional Antibody Catumaxomab (Anti-EpCAM x Anti-CD3)
Michael Jaeger et al.
CANCER RESEARCH (2012)
Epigenetic Resensitization to Platinum in Ovarian Cancer
Daniela Matei et al.
CANCER RESEARCH (2012)
Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness
Jing Cai et al.
CARCINOGENESIS (2012)
Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity
Appalaraju Jaggupilli et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
CD44+/CD24-ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival
Erhong Meng et al.
CLINICAL & EXPERIMENTAL METASTASIS (2012)
Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer
Adam D. Steg et al.
CLINICAL CANCER RESEARCH (2012)
A Phase II, Randomized, Placebo-Controlled Study of Vismodegib as Maintenance Therapy in Patients with Ovarian Cancer in Second or Third Complete Remission
Stanley B. Kaye et al.
CLINICAL CANCER RESEARCH (2012)
M1 and M2 Macrophages: Oracles of Health and Disease
Charles D. Mills
CRITICAL REVIEWS IN IMMUNOLOGY (2012)
MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells
Weiwei Cheng et al.
FEBS JOURNAL (2012)
The impact of novel retinoids in combination with platinum chemotherapy on ovarian cancer stem cells
Jenny M. Whitworth et al.
GYNECOLOGIC ONCOLOGY (2012)
Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant low-grade serous carcinoma of the ovary, peritoneum, or fallopian tube
Ignacio Romero Noguera et al.
GYNECOLOGIC ONCOLOGY (2012)
Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells
Ilona Kryczek et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Phase II Activity of Belinostat (PXD-101), Carboplatin, and Paclitaxel in Women With Previously Treated Ovarian Cancer
Don S. Dizon et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2012)
Hypoxia affects dendritic cell survival: Role of the hypoxia-inducible factor-1a and lipopolysaccharide
Antonella Naldini et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
CD133 expression associated with poor prognosis in ovarian cancer
Jing Zhang et al.
MODERN PATHOLOGY (2012)
Navitoclax (ABT-263) Reduces Bcl-xL-Mediated Chemoresistance in Ovarian Cancer Models
Maureen Wong et al.
MOLECULAR CANCER THERAPEUTICS (2012)
The developing cancer stem-cell model: clinical challenges and opportunities
Louis Vermeulen et al.
LANCET ONCOLOGY (2012)
A restricted cell population propagates glioblastoma growth after chemotherapy
Jian Chen et al.
NATURE (2012)
Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation
S. M. Kumar et al.
ONCOGENE (2012)
Active PI3K Pathway Causes an Invasive Phenotype Which Can Be Reversed or Promoted by Blocking the Pathway at Divergent Nodes
Jeffrey J. Wallin et al.
PLOS ONE (2012)
Human ovarian cancer stem/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance
Katia Meirelles et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy
Shannon M. McAuliffe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Atg7 Modulates p53 Activity to Regulate Cell Cycle and Survival During Metabolic Stress
In Hye Lee et al.
SCIENCE (2012)
Stem-Like Epithelial Cells Are Concentrated in the Distal End of the Fallopian Tube: A Site for Injury and Serous Cancer Initiation
Daniel Y. Paik et al.
STEM CELLS (2012)
Autocrine CCL5 Signaling Promotes Invasion and Migration of CD133+Ovarian Cancer Stem-Like Cells via NF-?B-Mediated MMP-9 Upregulation
Haixia Long et al.
STEM CELLS (2012)
MicroRNAs Reprogram Normal Fibroblasts into Cancer-Associated Fibroblasts in Ovarian Cancer
Anirban K. Mitra et al.
CANCER DISCOVERY (2012)
Expression of putative stem marker nestin and CD133 in advanced serous ovarian cancer
Q. Qin et al.
NEOPLASMA (2012)
Cytotoxic T Lymphocytes Efficiently Recognize Human Colon Cancer Stem-Like Cells
Satoko Inoda et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Targeting NF-κB and HIF-1 Pathways for the Treatment of Cancer: Part II
Jacek Wilczynski et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2011)
Targeting NF-κB and HIF-1 Pathways for the Treatment of Cancer: Part I
Jacek Wilczynski et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2011)
Phase 1b-2a Study to Reverse Platinum Resistance Through Use of a Hypomethylating Agent, Azacitidine, in Patients With Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer
Siqing Fu et al.
CANCER (2011)
Bone Marrow-Derived Myofibroblasts Contribute to the Mesenchymal Stem Cell Niche and Promote Tumor Growth
Michael Quante et al.
CANCER CELL (2011)
Ovarian cancer-associated fibroblasts contribute to epithelial ovarian carcinoma metastasis by promoting angiogenesis, lymphangiogenesis and tumor cell invasion
Yuan Zhang et al.
CANCER LETTERS (2011)
Aldehyde Dehydrogenase in Combination with CD133 Defines Angiogenic Ovarian Cancer Stem Cells That Portend Poor Patient Survival
Ines A. Silva et al.
CANCER RESEARCH (2011)
EMT and Stem Cell-Like Properties Associated with miR-205 and miR-200 Epigenetic Silencing Are Early Manifestations during Carcinogen-Induced Transformation of Human Lung Epithelial Cells
Carmen S. Tellez et al.
CANCER RESEARCH (2011)
Transient depletion of p53 followed by transduction of c-Myc and K-Ras converts ovarian stem-like cells into tumor-initiating cells
Takeshi Motohara et al.
CARCINOGENESIS (2011)
Acidic stress promotes a glioma stem cell phenotype
A. B. Hjelmeland et al.
CELL DEATH AND DIFFERENTIATION (2011)
Critical Appraisal of the Side Population Assay in Stem Cell and Cancer Stem Cell Research
Anna Golebiewska et al.
CELL STEM CELL (2011)
Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcome
Lijing Luo et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2011)
Identification of Cancer Stem Cells in Human Gastrointestinal Carcinoid and Neuroendocrine Tumors
Puja Gaur et al.
GASTROENTEROLOGY (2011)
Circulating tumor cells predict progression free survival and overall survival in patients with relapsed/recurrent advanced ovarian cancer
Andres Poveda et al.
GYNECOLOGIC ONCOLOGY (2011)
Side population is increased in paclitaxel-resistant ovarian cancer cell lines regardless of resistance to cisplatin
Yoichi Kobayashi et al.
GYNECOLOGIC ONCOLOGY (2011)
Exosomes from ovarian cancer cells induce adipose tissue-derived mesenchymal stem cells to acquire the physical and functional characteristics of tumor-supporting myofibroblasts
Jung Ah Cho et al.
GYNECOLOGIC ONCOLOGY (2011)
IMMUNOREGULATORY PROPERTIES OF CD44+CANCER STEM-LIKE CELLS IN SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Kazuaki Chikamatsu et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2011)
Dual Roles of Immune Cells and Their Factors in Cancer Development and Progression
Brian F. Zamarron et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2011)
Tumor associated mesenchymal stem cells protects ovarian cancer cells from hyperthermia through CXCL12
Raphael Lis et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Hedgehog signaling pathway regulates the growth of ovarian cancer spheroid forming cells
Anasuya Ray et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2011)
Human ovarian carcinoma-associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production
Karen McLean et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Targeting the Mitochondria Activates Two Independent Cell Death Pathways in Ovarian Cancer Stem Cells
Ayesha B. Alvero et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
Kristin M. Nieman et al.
NATURE MEDICINE (2011)
Prevalence of Epithelial Ovarian Cancer Stem Cells Correlates with Recurrence in Early-Stage Ovarian Cancer
Karina Dahl Steffensen et al.
JOURNAL OF ONCOLOGY (2011)
Notch3 Overexpression Is Related to the Recurrence of Ovarian Cancer and Confers Resistance to Carboplatin
Joon Tae Park et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Ovarian Cancer Development and Metastasis
Ernst Langyel
AMERICAN JOURNAL OF PATHOLOGY (2010)
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
Robert J. Kurman et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
TNF-α/NF-κB/Snail pathway in cancer cell migration and invasion
Y. Wu et al.
BRITISH JOURNAL OF CANCER (2010)
Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant
L. Hu et al.
BRITISH JOURNAL OF CANCER (2010)
A Phase 1 and Pharmacodynamic Study of Decitabine in Combination With Carboplatin in Patients With Recurrent, Platinum-Resistant, Epithelial Ovarian Cancer
Fang Fang et al.
CANCER (2010)
Modulation of T-Cell Activation by Malignant Melanoma Initiating Cells
Tobias Schatton et al.
CANCER RESEARCH (2010)
Double-Negative Feedback Loop between Reprogramming Factor LIN28 and microRNA let-7 Regulates Aldehyde Dehydrogenase 1-Positive Cancer Stem Cells
Xiaojun Yang et al.
CANCER RESEARCH (2010)
Identification of cancer stem cell-like cells from human epithelial ovarian carcinoma cell line
M. F. Shi et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Immunobiological Characterization of Cancer Stem Cells Isolated from Glioblastoma Patients
Tiziano Di Tomaso et al.
CLINICAL CANCER RESEARCH (2010)
Phase II trial of the histone deacetylase inhibitor belinostat in women with platinum resistant epithelial ovarian cancer and micropapillary (LMP) ovarian tumours
Helen J. Mackay et al.
EUROPEAN JOURNAL OF CANCER (2010)
RhoA/ROCK signaling is essential for multiple aspects of VEGF-mediated angiogenesis
Brad A. Bryan et al.
FASEB JOURNAL (2010)
Role of Magmas in protein transport and human mitochondria biogenesis
Devanjan Sinha et al.
HUMAN MOLECULAR GENETICS (2010)
Hospicells (ascites-derived stromal cells) promote tumorigenicity and angiogenesis
Marlene Pasquet et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
ULBP2 and RAET1E NKG2D ligands are independent predictors of poor prognosis in ovarian cancer patients
Roger W. McGilvray et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway
Her-Young Su et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Hypoxia-Inducible Factors and the Response to Hypoxic Stress
Amar J. Majmundar et al.
MOLECULAR CELL (2010)
Catumaxomab Clinical development and future directions
Rolf Linke et al.
MABS (2010)
Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer
S. Peng et al.
ONCOGENE (2010)
CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells
M-Q Gao et al.
ONCOGENE (2010)
Distinct Expression Levels and Patterns of Stem Cell Marker, Aldehyde Dehydrogenase Isoform 1 (ALDH1), in Human Epithelial Cancers
Shan Deng et al.
PLOS ONE (2010)
CD133 antigen expression in ovarian cancer
Gabriella Ferrandina et al.
BMC CANCER (2009)
Latent Bone Metastasis in Breast Cancer Tied to Src-Dependent Survival Signals
Xiang H. -F. Zhang et al.
CANCER CELL (2009)
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: N1 versus N2 TAN
Zvi G. Fridlender et al.
CANCER CELL (2009)
Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis
Kui Li et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Cancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cells
Craig Gedye et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
MiR-15a and MiR-16 Control Bmi-1 Expression in Ovarian Cancer
Resham Bhattacharya et al.
CANCER RESEARCH (2009)
Perioperative Activation of Disseminated Tumor Cells in Bone Marrow of Patients With Prostate Cancer
Dorothea Weckermann et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Epigenetic regulation of CD133 and tumorigenicity of CD133+ovarian cancer cells
T. Baba et al.
ONCOGENE (2009)
Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression
Erika L. Spaeth et al.
PLOS ONE (2009)
The Increasing Complexity of the Cancer Stem Cell Paradigm
Jeffrey M. Rosen et al.
SCIENCE (2009)
CD133 Expression Defines a Tumor Initiating Cell Population in Primary Human Ovarian Cancer
Michael D. Curley et al.
STEM CELLS (2009)
CD133-Expressing Stem Cells Associated with Ovarian Metastases Establish an Endothelial Hierarchy and Contribute to Tumor Vasculature
Anjali P. Kusumbe et al.
STEM CELLS (2009)
Stem-Like Ovarian Cancer Cells Can Serve as Tumor Vascular Progenitors
Ayesha B. Alvero et al.
STEM CELLS (2009)
Parallel progression of primary tumours and metastases
Christoph A. Klein
NATURE REVIEWS CANCER (2009)
An immunohistochemical perspective of PPARβ and one of its putative targets PDK1 in normal ovaries, benign and malignant ovarian tumours
N. Ahmed et al.
BRITISH JOURNAL OF CANCER (2008)
Identification and characterization of ovarian cancer-initiating cells from primary human tumors
Shu Zhang et al.
CANCER RESEARCH (2008)
MicroRNA expression profiling in human ovarian cancer:: miR-214 induces cell survival and cisplatin resistance by targeting PTEN
Hua Yang et al.
CANCER RESEARCH (2008)
MCF7 side population cells with characteristics of cancer stem/progenitor cells express the tumor antigen MUC1
Katja Engelmann et al.
CANCER RESEARCH (2008)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome
Richard W. Tothill et al.
CLINICAL CANCER RESEARCH (2008)
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
Sun-Mi Park et al.
GENES & DEVELOPMENT (2008)
Oct4 dependence of chromatin structure within the extended Nanog locus in ES cells
Dana N. Levasseur et al.
GENES & DEVELOPMENT (2008)
A phase II study of vorinostat in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study
Susan C. Modesitt et al.
GYNECOLOGIC ONCOLOGY (2008)
In vitro metformin anti-neoplastic activity in epithelial ovarian cancer
Walter H. Gotlieb et al.
GYNECOLOGIC ONCOLOGY (2008)
Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells
Lilly Y. W. Bourguignon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells
Zhen Lu et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Phase II evaluation of imatinib mesylate in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study
Russell J. Schilder et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Efficient tumour formation by single human melanoma cells
Elsa Quintana et al.
NATURE (2008)
Oncologic Trogocytosis of an Original Stromal Cells Induces Chemoresistance of Ovarian Tumours
Arash Rafii et al.
PLOS ONE (2008)
Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers
Nancy Dumont et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
ATF6α-Rheb-mTOR signaling promotes survival of dormant tumor cells in vivo
Denis M. Schewe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Mitochondria in cancer cells: what is so special about them?
Vladimir Gogvadze et al.
TRENDS IN CELL BIOLOGY (2008)
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Jane E. Visvader et al.
NATURE REVIEWS CANCER (2008)
Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells
Dorothee Duluc et al.
BLOOD (2007)
Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM
Steffen Runz et al.
GYNECOLOGIC ONCOLOGY (2007)
Genes that distinguish physiological and pathological angiogenesis
Steven Seaman et al.
CANCER CELL (2007)
Dormant tumor cells develop cross-resistance to apoptosis induced by CTLs or imatinib mesylate via methylation of suppressor of cytokine signaling 1
Aurore Saudemont et al.
CANCER RESEARCH (2007)
Epigenetic gene silencing in cancer: the DNA hypermethylome
Manel Esteller
HUMAN MOLECULAR GENETICS (2007)
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer
Junzo Hamanishi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Chromatin modifications and their function
Tony Kouzarides
CELL (2007)
Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma
Chunhula Lu et al.
CANCER RESEARCH (2007)
Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways
Rong Wu et al.
CANCER CELL (2007)
A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer
Michael H. Kershaw et al.
CLINICAL CANCER RESEARCH (2006)
Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness
Paul P. Szotek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Sequence mutations and amplification of PIK3CA and AKT2 genes in purified ovarian serous neoplasms
Kentaro Nakayama et al.
CANCER BIOLOGY & THERAPY (2006)
Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant epithelial ovarian and primary peritoneal cancers
RL Coleman et al.
GYNECOLOGIC ONCOLOGY (2006)
Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells
J Ren et al.
CANCER RESEARCH (2006)
The immunoregulatory effects of gangliosides involve immune deviation favoring type-2 T cell responses
Fabian A. Crespo et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
The SIRP family of receptors and immune regulation
AN Barclay et al.
NATURE REVIEWS IMMUNOLOGY (2006)
CpG island methylation of DNA damage response genes in advanced ovarian cancer
JM Teodoridis et al.
CANCER RESEARCH (2005)
Ovarian carcinoma cells and IL-1β-activated human peritoneal mesothelial cells are possible sources of vascular endothelial growth factor in inflammatory and malignant peritoneal effusions
S Stadlmann et al.
GYNECOLOGIC ONCOLOGY (2005)
Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer
SA Bapat et al.
CANCER RESEARCH (2005)
Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cells
P Gutwein et al.
CLINICAL CANCER RESEARCH (2005)
In vivo cervical cancer growth inhibition by genetically engineered cytotoxic T cells
P Dall et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Hypermethylation of the PTEN gene in ovarian cancer cell lines
T Schönorf et al.
CANCER LETTERS (2004)
c-KIT expression and correlation with chemotherapy resistance in ovarian carcinoma: an immunocytochemical study
AR Raspollini et al.
ANNALS OF ONCOLOGY (2004)
Proinvasive properties of ovarian cancer ascites-derived membrane vesicles
LE Graves et al.
CANCER RESEARCH (2004)
Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer
JD Wu et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
HIF activation by pH-dependent nucleolar sequestration of VHL
K Mekhail et al.
NATURE CELL BIOLOGY (2004)
Adipose tissue as an endocrine organ
EE Kershaw et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Contributions of cell metabolism and H+ diffusion to the acidic pH of tumors
PA Schornack et al.
NEOPLASIA (2003)
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
V Groh et al.
NATURE (2002)
CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival
G Kristiansen et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Characterization of the expression of MHC proteins in human embryonic stem cells
M Drukker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
β-catenin mutations and aberrant nuclear expression during endometrial tumorigenesis
M Saegusa et al.
BRITISH JOURNAL OF CANCER (2001)
Share Paper
